Comparison of two airway devices( Ambu Auragain and Proseal LMA) in laparoscopic cholecystectomy patients

A Comparative Evaluation of Ambu Auragain with Proseal LMA in patients undergoing laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/10/007402

Enrollment

Registered

2016-10-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- All participants will either be ASA (American society of Anaesthesiologists)grade 1 or 2

Interventions

Intervention1: AmbuAura Gain(AAG): It is a second generation single use supraglottic device that incorporates a gastric channel and has an integrated bite block .It is also anatomically shaped and fac

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA1 and 2 patients of either sex 2. 18 â?? 65 years of age 3. BMI â?? 18.5 â?? 30 4. Patients undergoing laparoscopic cholecystectomy under General Anaesthesia

Exclusion criteria

Exclusion criteria: 1. Restricted mouth opening( 2. Mallampati Grade (MPG) III/IV 3. Patients with airway morbidities( Respiratory tract infections, COPD etc) 4. Patients with BMI >30 5. Patients with risk of gastric aspiration( non-fasted, GERD) 6. Pregnancy 7. Patient refusal

Design outcomes

Primary

Measure	Time frame
Oropharyngeal Leak Airway PressuresTimepoint: After device placement	—

Secondary

Measure	Time frame
1. Ease of insertion (1- Easy 2- Difficult) and time taken (in sec) 2. Minimum cuff volume and pressure required to prevent leak 3. Pharyngeal mucosal Pressures Timepoint: Noted immediately after device placement	—

Countries

India

Contacts

Public ContactDr Kriti Singh

Batra Hospital and Medical Research Centre

pavan_gurha@yahoo.com9811088632

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026